Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
08/2003
08/21/2003US20030158256 (Arylaminoaceamido)acetonitrile derivatives
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158185 Novel use of phenylheteroakylamine derivatives
08/21/2003CA2476139A1 Process for the preparation of substituted 3-phenylaminopropane-1,2-diols
08/21/2003CA2472762A1 2-oxazolamines and their use as 5-ht2b receptor antagonists
08/20/2003EP1335724A1 Novel use of certain insulin sensitizers or ppar-gamma agonists
08/20/2003EP1150944B1 N2-phenylamidine derivatives
08/20/2003EP0970059B1 Disubstituted biphenyloxazolines
08/20/2003EP0923542B1 Aryl substituted cyclic amines as selective dopamine d3 ligands
08/20/2003CN1437581A Glucagon antagonists/inverse agonists
08/20/2003CN1118457C Cyclic diamine compound and medicine containing the same
08/19/2003US6608227 Benzylcycloalkyl amines as modulators of chemokine receptor activity
08/19/2003US6608066 Tissue factor antagonists and methods of use thereof
08/19/2003US6608057 Compounds useful as reversible inhibitors of cathepsin S
08/19/2003CA2099867C 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
08/14/2003WO2003066608A1 Catechol bioisosteres
08/14/2003WO2003066574A1 Aromatic amino acid derivatives and medicinal compositions
08/14/2003WO2003066565A1 Deuterated biphenyl derivatives
08/14/2003WO2003066546A1 Process for producing biaryl compound
08/14/2003WO2003065789A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/14/2003WO2003024955A3 Small molecule inhibitors of caspases
08/14/2003US20030153801 Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
08/14/2003US20030153768 Efficient synthesis of ceramide-like compounds by reacting an aldehyde and an amidomethylisonitrile to form a 4-amido-2-oxazoline; suppress biosynthesis of glycosphingolipids; antitumor agents; Tays-Sach, Gaucher's
08/14/2003US20030153579 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient
08/14/2003US20030153507 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
08/14/2003CA2473778A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/13/2003EP1334961A1 Process for the preparation of glycine-N,N-diacetic acid derivatives
08/13/2003CN1436187A Hetaryl-substd. heterocycles
08/13/2003CN1117750C 3-heterocyclyl-substd. benzoyl derivs.
08/13/2003CN1117738C Endothelin antagonists
08/12/2003US6605732 Clean, high-yield preparation of S,S and R,S amino acid isosteres
08/12/2003US6605721 Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors
08/12/2003US6605631 Ortho-substituted 2-methoxyiminophenyl-N-methylacetamides
08/12/2003US6605629 Oxazole derivatives; low toxicity
08/12/2003US6605609 N-(((5S)-3-(4-(1,1-dioxido-4-thiomorpholinyl)-3,5-difluorophen yl) -2-oxo-1,3-oxazolidin-5-yl)methyl)acetamide antimicrobial used in combination therapy
08/07/2003WO2003063862A1 Cotherapy with an oxazolidinone and a vitamin b
08/07/2003WO2003063576A2 Arylsulfonamidobenzylic compounds
08/07/2003WO2002051819A9 Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
08/07/2003US20030149264 Chiral ionic liquids
08/07/2003US20030149108 Linked biaryl compounds
08/07/2003US20030149006 New vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
08/07/2003US20030148387 Solution phase synthesis of arylbenzoxazoles
08/07/2003CA2474433A1 Arylsulfonamidobenzylic compounds
08/07/2003CA2473457A1 Cotherapy with an oxazolidinone and a vitamin b
08/06/2003EP1332131A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP1331922A1 Photo-labile pro-fragrance conjugates
08/06/2003EP1084103B1 New 3-aryl-2-hydroxypropionic acid derivative (i)
08/06/2003EP1058695B1 Method for cross-linking hydrogels with bis- and poly-2-oxazolidinones
08/06/2003EP1056787B1 Secondary cross-linking of hydrogels with 2-oxazolidinones
08/06/2003CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists
08/06/2003CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use
08/06/2003CN1117071C Pesticides
08/05/2003US6603031 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
08/05/2003US6603016 Reaction of alpha-, beta- or gamma- amino acid or one of its salts with phosgene, diphosgene and/or triphosgene in a solvent; a portion is carried out under a pressure of < 1000 mbar
08/05/2003US6603014 Use of cyclic enamines as light protection agents
08/05/2003US6603012 RAR selective retinoid agonists
08/05/2003US6602901 Antidiabetic agents, obesity
08/05/2003US6602876 Adhesion receptor antagonists
07/2003
07/31/2003WO2003062192A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
07/31/2003WO2003061552A2 Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone
07/31/2003WO2003045901A3 Guanidine derivatives
07/31/2003WO2003041649A3 Cyanoalkylamino derivatives as protease inhibitors
07/31/2003WO2003020677A3 C2-substituted indane-1-ones and their derivatives, method for their production and their use as medicaments
07/31/2003US20030144531 Preparing chirally pure S-enantiomers of alpha -amino acids comprising the steps of: a) preparing an organometallic reagent from an alkyl halide of the formula (R) 2CH(CH2)nCH2X; b) adding the organometallic reagent to carbon dioxide to form
07/31/2003US20030144526 Calcium receptor-active compounds
07/31/2003US20030144523 Epothilone derivatives, method for producing same and their pharmaceutical use
07/31/2003US20030144332 Diarylcycloalkyl derivatives, processes for their preparation and their use s pharmaceuticals
07/31/2003US20030144330 Peroxidase proliferator activated receptor (PPAR) gamma agonists for playing key role in inducing growth arrest by terminal differentiation of actively proliferating PPAR gamma-expressing cells, particularly transformed adipose cells
07/31/2003US20030144292 Protease inhibitors such as N-((4'-Methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl-N-methyl-amino)-(4 -hydroxycyclohexan-1-yl)-acetic acid for prophylaxis of neurodegenerative diseases, vision defects, skin disorders or as antiinflammatory agents
07/30/2003EP1331224A1 Thiazole or oxazole derivatives
07/30/2003EP1330432A2 Substituted alkanoic acids
07/30/2003EP0958296B1 Heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
07/30/2003CN1433415A N-[5-[[[5-alkyl-2-oxazlyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
07/30/2003CN1433408A Aminothiazole inhibitors of cyslin dependent kinases
07/30/2003CN1116288C Urea derivatives as inhibitors of inosine-5'-phospho-dehydrogenase
07/30/2003CN1116287C Diphenyl heterocycles as potassium channel modulators
07/29/2003US6600058 Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments
07/29/2003US6600048 Control barnyard grass produced from rice and composition as suitable herbicides.
07/29/2003US6600031 Methods of making nucleic acid or oligonucleotide arrays
07/29/2003US6599940 Neurotransmitters
07/29/2003US6599935 2-phenyl-1,3-propanediol dicarbamate derivatives used as antiepileptic and antiischemic agents
07/29/2003US6599923 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action
07/24/2003WO2003059895A1 Halogenobenzyl aminopropionic acid derivatives
07/24/2003WO2003059873A1 Potassium channel modulators
07/24/2003US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
07/24/2003US20030139404 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
07/24/2003US20030139390 Compounds for the modulation of PPARgamma activity
07/24/2003US20030139376 Lipoxin A4 analogs
07/24/2003CA2473207A1 Halogenobenzylaminopropionic acid derivatives
07/23/2003EP1328509A1 Methods of producing oxazolidinone compounds
07/23/2003EP1328508A2 Propionic acid derivatives with ppar-alpha activating properties
07/23/2003EP0888278B1 Antidiabetic agents
07/23/2003CN1431941A 挤压模 Extrusion die
07/23/2003CN1431197A Alanine class compound, its preparing method and use
07/22/2003US6596903 Ring opening 4-(2-amino-1-hydroxyethyl)oxazoline by reaction with organic mercaptan; stereospecific; human immunodeficiency virus protease inhibitors
07/22/2003US6596863 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis
07/22/2003US6596772 Relates to trifluoromethyl sulfonyl and trifluoromethyl sulfonamido compounds and the physiologically acceptable salts and the prodrugs thereof. These compounds are expected to modulate the activity of protein tyrosine enzymes which are
07/22/2003US6596747 For therapy of diseases associdated with Factor VIIa and or inosine monophosphate dehydrogenase (IMPDH)
07/22/2003US6596746 Cyclic protein tyrosine kinase inhibitors
07/22/2003US6596743 Carbamic acid derivatives